Advos

Commercial real estate owners are increasingly familiar with vertiport potential, shifting conversations from basic education to feasibility and partnership structures, signaling an inflection point for eVTOL infrastructure deployment.

Families inheriting property in Mississippi often make costly mistakes by assuming informal authority before probate, leading to legal and financial complications, according to Home Buyer Mississippi.

Dr. Robert Whitfield MD introduces targeted treatments for facial volume loss from GLP-1 weight loss drugs and non-surgical facelift options for Austin patients.

Dr. Robert Whitfield's clinical safety research on fat transfer breast augmentation, paired with a new explant option for Breast Implant Illness patients, highlights a personalized approach to health optimization through the SHARP Method.

Canamera Energy Metals Corp. is advancing its Brazilian rare earth projects with accelerated exploration and a new technical report, positioning itself in a sector critical for clean energy and technology supply chains.

Earth Science Tech Inc. (ETST) has repurchased 3.7 million shares over nine months while expanding its healthcare operations, signaling a focus on shareholder value and financial stability.

Quantum BioPharma Ltd. advances a pipeline targeting neurological diseases and alcohol metabolism, addressing unmet needs in multiple sclerosis and sobriety.

Trident Digital Tech Holdings Ltd. (NASDAQ: TDTH) announced the launch of TDTHAI, an AI platform aimed at enterprise deployment and digital transformation in Asia-Pacific, building on its existing initiatives including a potential $800 million Ghana joint venture.

A study in JACC: Advances found that HeartBeam's credit card-sized ECG device, combined with a risk algorithm, can accurately identify heart attack risk in chest pain patients, with AUC up to 92.9% when a baseline ECG is available.

BridgeCore Capital finances a McDonald's property in Saraland, Alabama with a $1.4 million bridge loan, enabling a quick acquisition and resale strategy.

Advanced Glazings celebrates the Grand Prix d'Excellence awarded to the Vaudreuil-Dorion Municipal Hub, highlighting the role of its SoleraWall System in creating a high-performance, daylight-filled civic space.

LIXTE Biotechnology Holdings announced a $16.6 million registered direct offering to fund strategic initiatives, including its cancer drug development and proton therapy systems.

Rail Vision Ltd. announced its AI-powered ShuntingYard system has been integrated into Railserve’s YardGUARD industrial railyard safety system, enhancing situational awareness and obstacle detection.

Dental implants remain the gold standard for tooth replacement, but high costs often deter patients; understanding pricing components, comparing providers, and exploring financing or dental tourism can make treatment more accessible.

Oncotelic Therapeutics announces the expansion of its Phase 1b clinical program for Sapu003 and the appointment of Global Clinical Trials to lead international study execution, marking a shift toward multinational development.

TransCode Therapeutics announced positive Phase 1a trial results for its microRNA-10b inhibitor TTX-MC138, showing safety and durable disease stabilization in advanced cancer patients, leading to Phase 2a advancement.

As AI data centers' electricity consumption is projected to double by 2030, companies like MAX Power Mining Corp. are exploring geologic hydrogen as a potential clean energy source, with the company confirming North America's first subsurface natural hydrogen system.

As drug-delivery markets head toward $410 billion, biotech companies like Oncotelic Therapeutics are leveraging platform technologies to enhance existing cancer therapies, shifting focus from novel drug discovery to scalable delivery systems.

Revolution Medicines' new pill daraxonrasib targets KRAS mutations and has reportedly doubled survival in early trials, offering hope against a notoriously resistant cancer.

Ferrari's announcement of its first fully electric vehicle, the Luce, has sparked pushback from investors and enthusiasts concerned about the brand's departure from its combustion-engine heritage.

The article explores how biotech firms are leveraging advanced drug-delivery technologies and AI, featuring Oncotelic's Sapu003 program, Deciparticle platform, and PDAOAI initiative as key examples.